JAMES INVESTMENT RESEARCH INC - UTAH MED PRODS INC ownership

Quarter-by-quarter ownership
JAMES INVESTMENT RESEARCH INC ownership history of UTAH MED PRODS INC
ValueSharesWeighting
Q3 2023$369,112
-7.7%
4,2920.0%0.05%
-3.9%
Q2 2023$400,014
+98183.5%
4,2920.0%0.05%
-5.6%
Q1 2023$407
-5.1%
4,292
+0.5%
0.05%
-10.0%
Q4 2022$429
-99.9%
4,2700.0%0.06%
+15.4%
Q3 2022$364,000
-0.8%
4,2700.0%0.05%
+6.1%
Q2 2022$367,000
-4.4%
4,2700.0%0.05%
+22.5%
Q1 2022$384,0004,2700.04%
Other shareholders
UTAH MED PRODS INC shareholders Q4 2023
NameSharesValueWeighting ↓
MORGAN DEMPSEY CAPITAL MANAGEMENT LLC 165,563$9,464,0002.95%
Bares Capital Management 398,937$22,803,0001.97%
Ativo Capital Management LLC 7,072$404,0000.18%
Penobscot Investment Management Company, Inc. 7,400$423,0000.15%
Wallace Capital Management Inc. 10,001$572,0000.13%
Ancora Advisors LLC 11,389$651,0000.10%
Hillsdale Investment Management Inc. 4,400$252,0000.07%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 36,300$2,075,0000.06%
CRAWFORD INVESTMENT COUNSEL INC 16,380$936,0000.03%
Teton Advisors, Inc. 5,174$296,0000.02%
View complete list of UTAH MED PRODS INC shareholders